#SFHS2604355AOrder Regarding Changes to Registration Conditions for Medical Telemonitoring of Gestational Diabetes
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This order modifies the registration conditions for medical telemonitoring of gestational diabetes in France. It primarily updates the effective date for the end of coverage for different telemonitoring solutions, extending them to July 1, 2026. This applies to the generic reference framework and specific solutions like MYDIABBY HEALTHCARE and GLOOKO XT.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- The generic reference framework now has a coverage end date of July 1, 2026.
- MYDIABBY HEALTHCARE's telemonitoring solution's coverage end date extended to July 1, 2026.
- GLOOKO XT's telemonitoring solution's coverage end date also extended to July 1, 2026.
Obligations
What this law requires
Update the generic reference framework registration annex to replace the 2-year duration clause with an end-of-coverage date of July 1, 2026 for medical telemonitoring of gestational diabetes
Modify the MYDIABBY HEALTHCARE solution registration annex (Article 2, Section V 'Conditions d'inscription') to set the end-of-coverage date to July 1, 2026
Modify the GLOOKO XT solution registration annex (Article 3, Section V 'Conditions d'inscription') to set the end-of-coverage date to July 1, 2026
Publish this order in the Journal officiel de la République française (Official Journal of the French Republic)
Update the generic reference framework registration conditions to reflect the new coverage end date of July 1, 2026, replacing the previous 2-year duration language